High COVID-19 mortality rates among those with liver disease, study finds
A new international study has found increased mortality rates from COVID-19 among people with chronic liver disease and cirrhosis and has called for patients with worsening liver function to be tested for…
COVID-19 triggers innovative collaboration in healthcare services, yet liver patient care suffers setbacks globally
In a webinar jointly run by EASL and the World Health Organization (WHO), virology and hepatology experts compared strategies in coping during the current pandemic. They described a rise in innovative, cooperative…
Transitioning to The Digital ILC 2020: 27–29 August, 100% digital
Given the continuing impact of the SARS-CoV-2 pandemic and resulting restrictions, EASL has decided to transition the onsite International Liver Congress™ 2020, planned for 25–28 August, to an immersive and exciting digital…